# reload+after+2024-01-20 23:35:24.009603
address1§143 Harley street
address2§Ground floor
city§London
zip§W1G 6BH
country§United Kingdom
phone§44 20 3617 8728
website§https://www.avoplc.com
industry§Medical Devices
industryKey§medical-devices
industryDisp§Medical Devices
sector§Healthcare
sectorKey§healthcare
sectorDisp§Healthcare
longBusinessSummary§Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
fullTimeEmployees§174
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Michael Jeffrey Sinclair', 'age': 80, 'title': 'Executive Chairman', 'yearBorn': 1943, 'fiscalYear': 2021, 'totalPay': 434416, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nicolas  Serandour', 'age': 48, 'title': 'CEO & Executive Director', 'yearBorn': 1975, 'fiscalYear': 2021, 'totalPay': 502965, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Prof. Stephen  Myers OBE', 'age': 76, 'title': 'Executive Director', 'yearBorn': 1947, 'fiscalYear': 2021, 'totalPay': 397717, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ed  Lee', 'title': 'COO & President of Europe', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Graham  Pughe', 'title': 'Senior Vice-President of Accounting', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Berengere  Pons-Chabord', 'title': 'Senior Vice-President of Corporate Finance', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Manuel  Gallas', 'title': 'Director of Technical & Engineering', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Navas', 'title': 'Vice President of Investor and Public Relations', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Bridget  Biggar', 'title': 'Director of  Human Resources', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Donatella  Ungaro', 'title': 'Managing Director of ADAM', 'fiscalYear': 2021, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1640908800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.093
currency§GBp
forwardEps§-4.5
exchange§LSE
quoteType§EQUITY
shortName§ADVANCED ONCOTHERAPY PLC ORD 25
longName§Advanced Oncotherapy plc
firstTradeDateEpochUtc§1154674800
timeZoneFullName§Europe/London
timeZoneShortName§GMT
uuid§9c178001-0b17-3ac1-b483-ff13b657c8e8
messageBoardId§finmb_30485320
recommendationKey§none
quickRatio§0.129
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
